Buy. Remember after the last offering the stock ran up to $1.40 from the $0.80's in a few months. Besides at 0.80/share its no big deal to buy 5-10 thousand shares. On a small positive note the offering was at 0.75/share and the stock has been trading at a premium of 5-7 cents all day. If you believe in their technology then you are getting in at rock bottom prices. I suspect that the management of ECTE is finding out that new drug development is VERY costly. They are complete novices.